A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT01990534 · COMPLETED
Trial details
- NCT number
- NCT01990534
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-14
- Primary completion
- 2016-03-24
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.